

Falls are a common problem for people living with Parkinson’s. A recent review estimated that some 60% of all people living with PD have experienced at least one fall. These can lead to injury and hospitalisation, as well as reduced mobility, quality of life, and life expectancy.
Accurate fall risk assessment is crucial for effective care planning for Parkinson’s Disease patients, but traditional assessments are often subjective and time consuming. This new study set out to see whether data gathered by wearable sensors during a brief test in clinic can predict the risk of falling in people with Parkinson’s over a period of five years. This could facilitate more effective and longer-term care planning.
The team from the NeuroMetrology lab at the Nuffield Department of Clinical Neurosciences collected data from 104 people with Parkinson’s Disease, without prior falls, using six wearable sensors. Patients were asked to carry out tasks during short data collection sessions, including a two-minute walk and a 30-second postural sway task. Alongside this the team used several commonly used questionnaires and clinical scales to assess disease severity and the patient’s own perception of their decline in mobility.
Machine learning methods were used to analyse the sensor measurements taken from participants at their first study visit, together with follow up data taken at 24 and 60 months. From this data they were able to identify the key features that distinguish people with Parkinson’s with and without risk of falling. The analysis revealed significant differences in features related to walking and posture between those who went on to have falls and those who did not.
more recommended stories
Action Video Games and Brain Health: Study Insights
Gaming and Brain Structure: What MRI.
Creatine May Boost Muscle Strength in Alzheimer’s Patients
Creatine Supplementation Shows Promise in Alzheimer’s.
New Drug STF-1623 Shows Promise in Treating Solid Tumors
STF-1623 Transforming ‘Cold’ Tumors into ‘Hot’.
Macrophage Microautophagy Supports Immune Readiness
A Breakthrough in Cellular Recycling Macrophages,.
The Role of α-Glucosidase in Type 2 Diabetes
α-Glucosidase Inhibition: Functional Food Compounds for.
Oral Bacteria Linked to Atherosclerosis
New Evidence Links Viridans Streptococci to.
CDI Test Shows Early Detection Potential in Alzheimer’s
Breakthrough Study Highlights Brain Blood Flow.
Prenatal Chlorpyrifos Exposure and Pediatric Brain Changes
A Growing Concern in Pediatric Neurodevelopment.
Valve Deterioration After TAVI: New Research Insights
The Growing Role of TAVI in.
FAST Walking Shows Promise in Post-Stroke Rehab
Stroke remains one of the leading.
Leave a Comment